Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 8
1946 21
1947 50
1948 29
1949 55
1950 21
1951 23
1952 19
1953 14
1954 23
1955 21
1956 31
1957 42
1958 47
1959 27
1960 29
1961 23
1962 40
1963 63
1964 88
1965 71
1966 116
1967 100
1968 138
1969 193
1970 165
1971 169
1972 180
1973 152
1974 123
1975 86
1976 90
1977 118
1978 89
1979 90
1980 107
1981 127
1982 128
1983 148
1984 163
1985 161
1986 202
1987 274
1988 270
1989 285
1990 282
1991 292
1992 316
1993 357
1994 403
1995 410
1996 490
1997 568
1998 646
1999 743
2000 990
2001 995
2002 1200
2003 1118
2004 1006
2005 1164
2006 1123
2007 1050
2008 1250
2009 1319
2010 1378
2011 1530
2012 1663
2013 1678
2014 1645
2015 1414
2016 1247
2017 1192
2018 1063
2019 550
2020 32
Text availability
Article attribute
Article type
Publication date

Search Results

30,893 results
Results by year
Filters applied: . Clear all
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A. Vranckx P, et al. Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3. Lancet. 2019. PMID: 31492505 Clinical Trial.
A Review on the New and Old Anticoagulants.
Myers K, Lyden A. Myers K, et al. Orthop Nurs. 2019 Jan/Feb;38(1):43-52. doi: 10.1097/NOR.0000000000000517. Orthop Nurs. 2019. PMID: 30676577 Review.
Alpelisib: First Global Approval.
Markham A. Markham A. Drugs. 2019 Jul;79(11):1249-1253. doi: 10.1007/s40265-019-01161-6. Drugs. 2019. PMID: 31256368 Review.
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial.
Juric D, Janku F, Rodón J, Burris HA, Mayer IA, Schuler M, Seggewiss-Bernhardt R, Gil-Martin M, Middleton MR, Baselga J, Bootle D, Demanse D, Blumenstein L, Schumacher K, Huang A, Quadt C, Rugo HS. Juric D, et al. JAMA Oncol. 2019 Feb 1;5(2):e184475. doi: 10.1001/jamaoncol.2018.4475. Epub 2019 Feb 14. JAMA Oncol. 2019. PMID: 30543347 Free PMC article. Clinical Trial.
30,893 results
Jump to page
Feedback